Rigel Pharmaceuticals Inc (RIGL) — SC 13G/A Filings
All SC 13G/A filings from Rigel Pharmaceuticals Inc. Browse 7 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (7)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Vanguard Group Amends Rigel Pharma Stake to 9.9%
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Rigel Pharmaceuticals Inc. As of Decemb -
Goldman Sachs Amends Rigel Pharma Stake on Dec 29, 2023
— Feb 5, 2024
Goldman Sachs Group Inc. filed an amended SC 13G/A on February 5, 2024, indicating a change in their beneficial ownership of Rigel Pharmaceuticals Inc. common s -
Soleus Capital Amends Rigel Pharma Stake as of Dec 31, 2023
— Feb 2, 2024
Soleus Capital Master Fund, L.P. filed an amended Schedule 13G/A on February 2, 2024, indicating a change in their beneficial ownership of Rigel Pharmaceuticals -
BlackRock Amends Rigel Pharma Stake (15th Update)
— Jan 25, 2024
BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of Rigel Pharmaceuticals Inc. common stock as of December 31, 2023. This
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX